Archive for December, 2019
December 30, 2019
- Focused on the development of digital communities, targeted marketing of branded digital content, and e-commerce opportunities
- Operating through three strategic divisions to encompass its market strategies and objectives
- 10-year growth plan includes a near-term rebranding strategy with addition of many new revenue streams to greatly increase Jerrick’s potential market value
- Balanced portfolio of revenue streams will ensure institutional stability
Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.
Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.
Vocal
Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.
Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.
All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.
In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.
Vocal for Brands
Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.
Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.
Growth Strategy
Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.
This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.
Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.
Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.
History & Management
Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.
Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.
Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.
Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.
For more information, visit the company’s website at https://Jerrick.media
NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Canada NewsWire
TORONTO, Dec. 30, 2019
Horizons ETFs has completed its final marijuana ETFs rebalance of 2019
TORONTO, Dec. 30, 2019 – Horizons ETFs Management (Canada) Inc. (“Horizons ETFs“) has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ”:TSX), the Horizons US Marijuana Index ETF (“HMUS”:NEO) and the Horizons Emerging Marijuana Growers Index ETF (“HMJR”:NEO).
HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that have significant business activities in the marijuana industry. Amid contraction within the marijuana sector, seven constituents were removed from HMMJ’s portfolio:
Deletions
Company Name |
Ticker |
Exchange |
Heritage Cannabis Holdings Corp |
CANN |
Canadian Securities Exchange |
Emerald Health Therapeutics |
EMH |
TSX Venture Exchange |
Eve & Co Inc |
EVE |
TSX Venture Exchange |
Fsd Pharma Inc |
HUGE |
Canadian Securities Exchange |
48North Cannabis Corp |
NRTH |
TSX Venture Exchange |
Radient Technologies Inc |
RTI |
TSX Venture Exchange |
Zenabis Global Inc |
ZENA |
Toronto Stock Exchange |
HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. This index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. The North American Marijuana Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bioproducts and other ancillary businesses related to the marijuana industry. Securities within HMMJ’s index generally have a market capitalization of greater than CAD $75 million.
“The performance of the Marijuana sector in Q4 was quite disappointing. As a result, the market capitalization of a number of HMMJ’s holdings fell below their minimum inclusion threshold, leading to their removal from the index and the ETF,” said Steve Hawkins, President and CEO of Horizons ETFs. “Within HMMJ’s portfolio, this has resulted in the survival of the fittest: HMMJ’s holdings are now more concentrated on companies that are maintaining a strong position within the cannabis industry, despite difficult market conditions.”
Rebalancing of the North American Marijuana Index, and consequently HMMJ, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMMJ and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMMJ.
Performance Update as at December 20, 2019*
|
1 Month |
3 Month |
6 Months |
YTD |
1 Year |
Annualized
Since Inception** |
HMMJ |
-4.48% |
-34.28% |
-51.52% |
-34.71% |
-34.76% |
0.73% |
NAMMAR Index |
-5.77% |
-32.43% |
-51.08% |
-34.51% |
-34.55% |
-6.26% |
TX60AR Index |
0.58% |
1.77% |
4.58% |
22.52% |
23.95% |
7.08% |
* Source: Bloomberg, as at December 20, 2019. ** Since HMMJ’s inception on April 4, 2017.
The indicated rates of return are the historical annual compounded total returns, including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Additionally, index returns do not take into account management, operating or trading expenses that may be incurred in replicating the index. The rates of return above are not indicative of future returns. ETFs are not guaranteed, their values change frequently, and past performance may not be repeated. The indices are not directly investible.
HMUS REBALANCE
Launched in April 2019, HMUS is the world’s first U.S.-focused marijuana index ETF.
HMUS seeks to replicate, to the extent possible, the performance of the US Marijuana Companies Index, net of expenses. This index is designed to provide exposure to the performance of a basket of publicly-listed companies having significant business activities in, or significant exposure to, the marijuana or hemp industries in the United States. Constituents of this index are selected from Canadian and U.S. exchanges. While some securities may be listed on major North American exchanges, the majority of the securities currently trade on North American exchanges that include but are not limited to the Canadian Securities Exchange and the Aequitas NEO Exchange.
This rebalance resulted in the removal of seven companies:
Deletions
Company Name |
Ticker |
Exchange |
Chemesis International Inc |
CSI |
Canadian Securities Exchange |
Dixie Brands Inc |
DIXI |
Canadian Securities Exchange |
4front Ventures Corp |
FFNT |
Canadian Securities Exchange |
High Tide Inc |
HITI |
Canadian Securities Exchange |
Rubicon Organics Inc |
ROMJ |
Canadian Securities Exchange |
Sol Global Investments Corp |
SOL |
Canadian Securities Exchange |
1933 Industries Inc |
TGIF |
Canadian Securities Exchange |
“We continue to believe that the United States has the potential be the world’s largest cannabis market from an investment perspective,” said Mr. Hawkins. “Several instances of key federal and state-level legislation have signalled progress on greater cannabis liberalization in the country, including the SAFE Banking Act, the MORE Act, and the legalization of recreational cannabis in Illinois. We are optimistic about what’s in store for the United States’ cannabis sector in 2020.”
Rebalancing of the US Marijuana Companies Index, and consequently HMUS, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMUS and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMUS.
HMJR REBALANCE
HMJR seeks to replicate, to the extent possible, the performance of the Emerging Marijuana Growers Index, net of expenses. This index is designed to provide exposure to the performance of a basket of primarily North American publicly-listed small-capitalization companies primarily involved in the cultivation, production and/or distribution of marijuana.
HMJR invests in companies with market capitalizations generally between CAD $50 million and CAD $500 million. The ETF’s portfolio is 100% invested in marijuana producers and distributors, and it can have exposure to companies outside of North America.
The HMJR portfolio recently expanded to include the following eight constituents:
Additions
Company Name |
Ticker |
Exchange |
Ayr Strategies Inc |
AYR.A |
Canadian Securities Exchange |
C21 Investments Inc |
CXXI |
Canadian Securities Exchange |
Ianthus Capital Holdings Inc |
IAN |
Canadian Securities Exchange |
Medmen Enterprises Inc |
MMEN |
Canadian Securities Exchange |
Cannaroyalty Corp |
OH |
Canadian Securities Exchange |
Seach Medical Group Ltd |
SEMG |
Tel Aviv Stock Exchange |
Sundial Growers Inc |
SNDL |
NASDAQ |
Green Organic Dutchman Holdings |
TGOD |
Toronto Stock Exchange |
The following 20 companies were removed from HMJR’s portfolio on this rebalance:
Deletions
Company Name |
Ticker |
Exchange |
Choom Holdings Inc |
CHOO |
Canadian Securities Exchange |
Creso Pharma Ltd |
CPH |
Australian Securities Exchange |
Chemesis International Inc |
CSI |
Canadian Securities Exchange |
Dixie Brands Inc |
DIXI |
Canadian Securities Exchange |
Delta 9 Cannabis Inc |
DN |
Toronto Stock Exchange |
Emerald Health Therapeutics |
EMH |
TSX Venture Exchange |
Eve & Co Inc |
EVE |
TSX Venture Exchange |
Exmceuticals Inc |
EXM |
Canadian Securities Exchange |
FSD Pharma Inc |
HUGE |
Canadian Securities Exchange |
Harvest One Cannabis Inc |
HVT |
TSX Venture Exchange |
Integrated Cannabis Co Inc |
ICAN |
Canadian Securities Exchange |
James E Wagner Cultivation Cor |
JWCA |
TSX Venture Exchange |
Mjardin Group Inc |
MJAR |
Canadian Securities Exchange |
Mgc Pharmaceuticals Ltd |
MXC |
Australian Securities Exchange |
Ravenquest Biomed Inc |
RQB |
Canadian Securities Exchange |
Sunniva Inc |
SNN |
Canadian Securities Exchange |
Sproutly Canada Inc |
SPR |
Canadian Securities Exchange |
Wildflower Brands Inc |
SUN |
Canadian Securities Exchange |
THC Global Group Ltd |
THC |
Australian Securities Exchange |
Westleaf Inc |
WL |
TSX Venture Exchange |
Rebalancing of the Emerging Marijuana Growers Index, and consequently HMJR, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMJR and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMJR.
About Horizons ETFs Management (Canada) Inc. (www.HorizonsETFs.com)
Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has approximately $10 billion of assets under management and 91 ETFs listed on major Canadian stock exchanges.
Commissions, management fees and expenses all may be associated with an investment in exchange traded products (the “Horizons Exchange Traded Products”) managed by Horizons ETFs Management (Canada) Inc. The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.
There are risks associated with this product. HMUS is expected to invest in the Marijuana industry in certain U.S. states that have legalized marijuana for therapeutic or adult-use, which is currently illegal under U.S. federal law. HMUS will passively invest in companies involved in the marijuana industry in the U.S. where local state law regulates and permits such activities, as well as in companies involved in the Canadian legal Marijuana industry. HMUS will not be directly engaged in the manufacture, importation, possession, use, sale or distribution of marijuana in either Canada or the U.S. Please read the full risk disclosure in the prospectus before investing.
SOUTH EASTON, Mass., Dec. 30, 2019 — via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research (“Zacks SCR”) has released an updated research report in its on-going coverage on the Company.
Copies of the new Zacks SCR report can be obtained via the following link:
PBIO: Looking ahead to 2020
Any opinions, judgments, estimates, or forecasts regarding the Company’s historical or predicted performance or operations made by Zacks SCR are theirs alone and do not represent opinions, judgments, estimates, or forecasts of the Company or its management. The Company does not by its reference to the research prepared by Zacks SCR imply its endorsement or adoption of or concurrence with such information, conclusions, or recommendations.
About Zacks Small Cap Research
Zacks Small Cap Research (“Zacks SCR”) is a division of Zacks Investment Research. Zacks SCR coverage specifically looks to focus on small and micro-cap companies that are underfollowed or undervalued by Wall Street. Our analysts seek to identify and report on these companies, bringing to investors a unique opportunity to gain insight on small cap investments that are believed to be undervalued and well-positioned for future growth. Our goal is to produce high quality (institutional) research for the small cap portfolio.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law. Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Investor Contacts:
Richard T. Schumacher, President and CEO, (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman of the Board, (650) 812-8121 (T)
For more information about PBI and this press release, please click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
Predictive Oncology (NASDAQ: POAI), through its subsidiary Helomics, is sequencing ovarian cancers as part of a CancerQuest 2020 project, building the largest ovarian multi-omic database in the world. An article discussing the company reads, “As part of its CancerQuest 2020 project, Predictive Oncology, through Helomics, recently signed a collaborative agreement with UPMC-Magee to establish a data- and artificial-intelligence-driven approach to treating ovarian cancer. Based on the agreement, the partnership is designed to validate the significant value of using AI-powered decision-making for identifying specific treatments on specific genotypes to predict clinical outcomes for ovarian cancer patients. . . . Helomics has also begun sequencing retrospective ovarian cancer cases from the UPMC-Magee collaboration (http://nnw.fm/peQC8). As part of the sequencing process, Helomics is analyzing the mutations in the tumor (genome) and the expression of genes (transcriptome) in order to build a comprehensive multi-omic picture of the tumor. That information can then be brought together with Helomics’ data set of drug-response profiles to build an AI-driven predictive model of ovarian cancer.”
To view the full article, visit http://nnw.fm/uZD3r
About Predictive Oncology Inc.
Predictive Oncology (NASDAQ: POAI) operates through five segments (domestic, international, clinical, CRO and DCHIP), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary, precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered, proprietary bioinformatics platform (D-CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Kelowna, British Columbia – December 30, 2019 – Lexaria Bioscience Corp. (OTC:LXRP) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that on December 30, 2019 it issued stock options to an employee to purchase up to 60,000 common shares of the Company at an exercise price of US$0.43 for a period of five years, vested over a three year term.
Lexaria also announces that it has cancelled 550,000 options with an exercise price of US$0.10 per common share which were held by an insider of the Company.
About Lexaria
Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide.
www.lexariabioscience.com
For regular updates, connect with Lexaria on Twitter (https://twitter.com/lexariacorp)
and on Facebook https://www.facebook.com/lexariabioscience/
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Bioscience Corp.
Chris Bunka, CEO
(250) 765-6424
Or
NetworkNewsWire (NNW)
www.NetworkNewsWire.com
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional patent protection will be realized or that patent achievements will deliver material results. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance the Company will be capable of developing, marketing, licensing, or selling edible products containing cannabinoids, nicotine or any other active ingredient. There is no assurance that any planned corporate activity, scientific research or study, business venture, letter of intent, technology licensing pursuit, patent application or allowance, consumer study, or any initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease.
Sigma Labs (NASDAQ: SGLB), a developer of quality-assurance software for the commercial 3D-printing industry, has developed a method of overcoming quality-assurance obstacles that thwart 3D-metal printing from becoming fully integrated into modern manufacturing lines. An article discussing the company reads, “The company is about to revolutionize commercial 3D-printing metal by enabling nondestructive quality assurance during the production process. Sigma Labs’ proprietary PrintRite3D software is a real-time, computer-aided inspection (‘CAI’) technology long sought by 3D-printing companies to lower costs and increase yields. PrintRite3D(R) represents a breakthrough in the 3D-quality inspection sphere because it is the only known real-time, in-process, quality-assurance software for the commercial 3D-metal-printing industry. . . . 3D printing, also called additive manufacturing, is a technology that allows producers to transform a 3D-digital model of an object into a physical one by adding material rather than subtracting it, hence the additive in the name. The resulting 3D objects are made in a digitally controlled and operated process by depositing minuscule layers of material onto a substrate layer.”
To view the full article, visit http://nnw.fm/1f7Pi
About Sigma Labs Inc.
Sigma Labs (NASDAQ: SGLB) is a leading provider of quality-assurance software to the commercial, 3D-printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (CAI) solutions known as PrintRite3D for 3D advanced-manufacturing technologies. Sigma Labs’ advanced, computer-aided, software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production and uniquely allowing errors to be corrected in real time. For more information, visit the company’s website at www.SigmaLabsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Developer of quality-assurance software for the commercial 3D-printing industry Sigma Labs Inc. (NASDAQ: SGLB) recently demonstrated the latest version of its proprietary technology PrintRite3D(R) in collaboration with Materialise NV at the Formnext 2019 conference held in Frankfurt, Germany. A recent article discussing the company reads, “At the event, Sigma Labs’ chief technology officer Darren Beckett presented on ‘The Integration of PrintRite3D Melt Pool Monitoring Software with Materialise’s Machine Control Platform (MCP) for Advanced Process Control.’ The presentation showcased version 5.2 of the software, which features several software enhancements including the automated anomaly detection with Z connectivity that identifies thermal defects, which propagate across multiple layers and enhanced data-trend analysis and customizable thresholding that enable automatic alerts. These new functionalities should further strengthen the capabilities of additive manufacturing for serial production.”
To view the full article, visit http://nnw.fm/wM325
About Sigma Labs Inc.
Sigma Labs (NASDAQ: SGLB) is a leading provider of quality-assurance software to the commercial 3D-printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (CAI) solutions known as PrintRite3D for 3D advanced manufacturing technologies. Sigma Labs’ advanced, computer-aided, software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time. For more information, visit the company’s website at www.SigmaLabsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
December 27, 2019
Players in the hemp sector could finally heave a sigh of relief after the U.S. Department of Agriculture released the much-awaited interim final rule on hemp this October. Published in the Federal Register on October 31, the rule established a domestic hemp production program authorized by the Agricultural Improvement Act of 2018, also known as the Farm Bill.
When the 2018 Farm Bill legalized industrial hemp and its extracts last year, the market for hemp and hemp-derived CBD exploded. By the end of 2018, the CBD market was worth at least $8 billion, and it’s expected to hit $20 billion by 2026. However, there was one drawback to such swift growth.
Regulatory authorities were stuck playing catch up, resulting in an unregulated industry teeming with thousands of untested products each claiming untold medical benefits, which was very unsafe for consumers. On top of that, essential service providers avoided working with hemp growers fearing repercussions from law enforcement.
Unfortunately, the USDA’s interim final rule wasn’t the Hail Mary many thought it would be. Complaints abound that the regulations laid out by the USDA for the budding hemp sector are too stringent, and they may bring the industry down before it can truly soar.
When the interim rule was published, the USDA granted stakeholders a comment period to offer their own opinions on the new hemp rules. In a bid to get more feedback, the agency has announced that the comment period on its interim final hemp rule has been extended by 30 days to January 29.
Scott Propheter, Vice President of Agronomy and Outreach at Criticality, a North Carolina based hemp and CBD producer, urges growers to take advantage of this extension and reach out to their state agriculture departments and members of Congress.
“The USDA is going to be working directly with state regulators on this, so the more growers are involved with their state departments of agriculture the better off we’re going to be,” he says.
He adds that state regulators are on the growers’ side, even if it doesn’t always seem so. The interim final rule on hemp puts the burden on both growers and the state, and regulators want to work closely with growers to find the best solution to an increasingly complex issue.
Ben Marcus co-owns Sheepscot General Store and Farm, a farm and retailer in Whitefield, and he agreed stating that his state regulators have been invaluable in sharing insights.
“They’re not just going to test people’s crops to make sure everybody’s in compliance, but they’re helping us to understand the tumultuous political process that this is going through right now.”
He encourages farmers all across the country to reach out to their state lawmakers. “We don’t work for them, they work for us, so use them.”
This extension of the comments period is likely to be welcome news to hemp industry players like Dama Financial and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) who see it as an opportunity for a lot more people to voice their concerns regarding the interim hemp rules.
About HempWireNews
HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.HempWireNews.com
Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer
Do you have a questions or are you interested in working with HWN? Ask our Editor
HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net
HempWireNews is part of the InvestorBrandNetwork.
During the past trading week (December 23 to 27), a prominent C-level executive was dismissed from his role at one of Canada’s largest cannabis companies.
Another Canadian cannabis firm saw a massive value drop on its announcement of a US$25 million registered direct offering, which will dilute the value of its existing shares.
Here’s a closer look at some of the biggest cannabis news over the week.
Aurora Cannabis dips during volatile week
In a sudden move, one of Aurora Cannabis’ (NYSE:ACB,TSX:ACB) more front-facing executives, Cam Battley, “stepped down” from his role as chief corporate officer, the company announced, ending his three year stint with Aurora.
A news release sent out last Saturday (December 21) was followed by a 6.4 percent drop in Aurora’s share value in Toronto on Monday (December 23).
The slump continued across the week, and the company opened at C$2.55 on Friday (December 27), its lowest point year-to-date.
While Aurora did not mention the specific reason for Battley’s shift, the company confirmed he gained a role as a member of the board of directors for privately held medical cannabis company MedReleaf Australia in November. Aura holds a 10 percent stake in this venture, as well as 50 percent voting rights.
In the statement, Aurora CEO Terry Booth congratulated Battley on his work with the company. “We are grateful for Cam’s leadership and passion over his many years with Aurora. I am sure Cam will be successful as he moves on to tackle Australia,” he said.
Things took another dramatic turn, however, when it was revealed that Battley was asked to step down from his role. In an emailed statement to the Canadian Press, it wasn’t made clear why Battley was let go, but Aurora did say the move was a part of its effort to restructure its leadership strategy.
The rocky week continued for Aurora after The Coca-Cola Company (NYSE:KO) ended speculation that it plans to enter the cannabis market.
After the release of a since-deleted YouTube video in which a user claimed the firm was looking to launch a line of cannabidiol-infused Coca-Cola drinks in Canada, the company said it has no plans to throw its hat into the cannabis ring.
“These rumors are untrue,“ Coca-Cola said in an emailed statement to Bloomberg News. “As we have stated many times, we have no plans to enter the CBD market.”
Back in 2018, a BNN Bloomberg report indicated that the Georgia-based drink maker was in “serious talks” with the Canadian cannabis firm to create cannabis-infused beverages, which caused a boost for Aurora
HEXO faces losses following share sale
Beleaguered cannabis company HEXO (NYSE:HEXO,TSX:HEXO) stumbled again this week after its US-listed shares dropped over 20 percent following the announcement of an agreement with institutional investors for the purchase and sale of almost 15 million of its common shares for US$25 million.
The Quebec-based cannabis company told investors on Thursday (December 26) that it plans to use the proceeds as working capital to fund its research and development operations, among other corporate purposes.
HEXO took a hit earlier this month with the release of its fiscal Q1 2020 results. It reported a net loss of C$62.4 million in the quarter, a 10.1 percent rise from the C$56.7 million reported in Q4 2019.
The company blamed a slow retail opening in key Canadian provinces for its disappointing results.
During an earnings call with investors and analysts, HEXO CEO Sebastien St-Louis said, “We don’t believe that the retail channel will be substantially built until the end of 2021 or part way through 2022. The illicit market channel will continue to thrive until retail access is brought to the majority of Canadians.”
Year-to-date, HEXO has fallen 57.9 percent in New York.
Market updates
On Tuesday (December 24), Origin House (CSE:OH,OTCQX:ORHOF) reminded shareholders of the Friday (December 27) deadline for voting on its acquisition by Cresco Labs (CSE:CL,OTCQX:CRLBF).
According to Origin House, an overwhelming majority — over 99 percent — of shareholders have already voted in favor of the transaction.
The announcement came after Cresco Labs confirmed the all-stock deal — once called the “largest-ever public company acquisition” in the US cannabis industry — will move forward on reduced terms with a non-brokered financing on the part of Origin House of over 9.7 million of its own shares. The new deal is supposed to help reinforce the balance sheet of the combined company, Cresco said in a statement.
The Green Organic Dutchman (TSX:TGOD,OTCQX:TGODF) closed its previously announced senior secured credit facility of up to C$42.7 million with Maynbridge Capital.
This comes during a trying time for the firm, which has scrambled to acquire capital. It got its hands on C$103 million in funding in November, only to scrap that deal two weeks later in favor of an offering agreement with Canaccord Genuity to raise C$22 million in gross proceeds.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
LOS ANGELES, Dec. 27, 2019 — SRAX, Inc. (Nasdaq: SRAX), a digital marketing and consumer data management technology company, has extended the expiration time for its special dividend right from December 31, 2019 to on or before 5:00 p.m., ET, on December 31, 2020.
Special Dividend, Dividend Right and Expiration Date
On September 17, 2018, the company issued a non-transferable right (“Dividend Right”) to receive at no charge a special dividend to holders of the company’s Class A common stock as well as certain holders of the company’s common stock equivalents. If and when declared, the Special Dividend consisting of such number and designation of the SRAX subsidiary BIGtoken, Inc.’s securities (“Special Dividend”) as determined by the company’s management at their sole discretion. The Dividend Right was set to expire on or before 5:00 p.m., ET, on December 31, 2019, unless extended by the Company (the “Expiration Time”). The Dividend Right will now expire if the Special Dividend is not declared on or before 5:00 p.m., ET, on December 31, 2020, unless further extended by the company.
The Special Dividend will be an analog security, i.e., not digital, and not a cryptocurrency, and the Special Dividend is expected to be a fractional non-voting security that, if and when issued, is expected to only participate in a portion of the financial performance of the BIGtoken platform.
Transfer Agent and Questions
For further questions regarding the Dividend Right, please contact the information agent at:
Transfer Online, Inc.™
512 SE Salmon St., Portland, OR 97214
+1 (503) 227-2950
Advisement
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any term or condition contained in this press release, other than the claim that the Special Dividend will be analog and not digital, nor a cryptocurrency, is made based on the Company’s information, beliefs and anticipated development as of the date hereof. The Company reserves that right to alter, modify, or change any other term herein based on future developments.
THE DECLARATION AND ISSUANCE OF THE SPECIAL DIVIDEND IS SUBJECT TO SUBSTANTIAL STATE AND FEDERAL REGULATION AS WELL AS THE POSSIBLE APPROVAL OF ANY EXCHANGE ON WHICH THE SHARES OF SOCIAL REALITY, INC. ARE TRADED. ACCORDINGLY, WE CAUTION ANY HOLDER THAT THE SPECIAL DIVIDEND MAY NEVER BE DECLARED AND EVEN IF DECLARED, ULTIMATELY MAY NOT BE ISSUE. THE HOLDER IS CAUTIONED TO NOT PLACE ANY RELIANCE UPON ITS ABILITY TO RECEIVE THE SPECIAL DIVIDEND IN THE FUTURE OR THE VALUE, IF ANY, THAT SUCH SPECIAL DIVIDEND MAY HAVE.
About SRAX
SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information on SRAX, visit www.srax.com.
About BIGtoken
BIGtoken, built by SRAX (NASDAQ: SRAX), is a consumer data management and distribution system. BIG is the first consumer-managed data marketplace where people can own and earn from their data. Through a transparent platform and consumer reward system, BIG offers consumers choice, transparency, and compensation for their data. Participating consumers earn rewards, and developers are able to build pro-consumer online experiences on top of the BIG platform. The system also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. For more information on BIGtoken, visit www.bigtoken.com.
Safe Harbor Statement
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words or expressions such as “anticipate,” “plan,” “will,” “intend,” “believe” or “expect'” or variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to expectations of our ability to increase our revenues, satisfy our obligations as they become due, report profitable operations and other risks and uncertainties as set forth in our Annual Report on Form 10-K for the year ended December 31, 2018, and our subsequent Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of SRAX and are difficult to predict. SRAX undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
Data and artificial-intelligence (“AI”) driven, discovery-services company Predictive Oncology’s (NASDAQ: POAI) subsidiary TumorGenesis is developing quicker, less costly and more precise Patient Derived Xenograft (“PDx”) cancer models that better mimic the patient’s tumor. An article discussing the company reads, “TumorGenesis excels not only in identifying cancer cell lines but also in developing a medium necessary to grow cancer-cell colonies in a way that will not compromise their integrity — a consideration critical to the success of every cancer research. This revolutionary technology is creating an unparalleled competitive advantage for the parent company POAI, as it allows for faster and more accurate identification of tumors and the development of patient-specific treatment options. The company expects this revolutionary product to hit the market by the end of the year. . . . What is unique with TumorGenesis’ state-of-the-art approach to cancer research is that the company has already developed 25 validated, ovarian, cancer-cell types that mature into uncompromised tumor colonies not only in vitro but in rats and mice too — a formidable accomplishment as 15 out of 25 cell lines represent around 90% of all ovarian cancers discovered so far, including those most virulent and deadly.”
To view the full article, visit http://nnw.fm/CmD6B
About Predictive Oncology Inc.
Predictive Oncology (NASDAQ: POAI) operates through five segments (domestic, international, clinical, CRO and DCHIP), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary, precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered, proprietary bioinformatics platform (D- CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
December 3, 2019
- SRAX holds competitive advantage as big brands seek solutions that legacy partners cannot address
- Thousands joining BIGtoken platform daily with minimal marketing
- Four nonprofits, three CPG brands added to opt-in platform, increasing usage, reputation and reach
SRAX Inc. (NASDAQ: SRAX) sits at the epicenter of consumer privacy and data ownership. Leveraging its BIGtoken platform, the Company has made it possible for consumers to own their own data and get paid for the release of that data while also creating specific data sets around highly valuable verticals. On November 13, 2019, SRAX hosted a conference call for executives to share Q3 earnings and a forward look into Q4 with investors (http://nnw.fm/72m3W).
“Consumers are awakening to their online privacy and value exchange that exists for their personal information,” George Stella, SRAX’s vice president for brands and shopper marketing, stated in a news release. “Privacy regulations are happening fast now with California or CCPA and other states taking hold, and these conditions are creating a competitive advantage for us because big brands are moving to find solutions that their legacy partners can no longer address.”
These changes, both in the United States and globally, along with the ability to provide brands with a complete view of a consumer’s journey, have given SRAX a distinct competitive advantage. The BIGtoken platform is the means by which consumers are enabled to own their own data. As of the call, subscriber base has grown to 16.3 million users with minimal marketing spending, positioning the Company as a leader in this space. The platform continues to see anywhere from 3,000 to 10,000 people join a day.
The platform has expanded globally and is listed in the top 100 applications in the App Store and Google Play. The opt-in, user-controlled data set has proven to be the perfect remedy to GDPR’s impact. In addition to the acceptance it has seen in the 28 member countries of the European Union, the platform has also seen significant growth in Brazil, Indonesia, Italy and the Philippines. SRAX is strongly positioned to conduct research worldwide for big brand global organizations.
During Q3, BIGtoken added the ability for consumers to donate their earnings to the American Heart Association, HealthCorps, The ALS Association and Keep a Child Alive. Users from more than 20 countries have already donated to these nonprofits. During this same time, the Company’s BIG Rewards program, an exclusive offer for consumers to redeem earnings at specific retailers, added Procter & Gamble, Kraft and Sun-Maid. These three major CPG brands evaluated the platform and saw it as an innovative way to gain quality data.
The BIG Rewards program creates additional revenue for the organization while also bringing new users to the BIGtoken platform. The program allows companies access to a user base that has high privacy settings on social media, a consumer group that brands might typically have a hard time reaching.
A second platform, SRAX IR, is focused on helping CEOs and CFOs identify, manage and communicate with their investor base in groundbreaking ways. A few of the platform’s features include the ability to track shareholders’ behaviors and trends over time, get real-time market data including your company’s level two data, and engage shareholders across marketing channels including social media, email, and programmatic. Subscribing companies can utilize SRAX to turn their shareholder base into a revenue stream.
Additional verticals allow SRAX to sell access to specific data sets to an increasing number of brands. The two platforms are being leveraged to build crossover into the verticals. “We spent the past few quarters integrating our platforms and realigning the sales process and are now well positioned for growth,” added SRAX CEO Christopher Miglino. “Looking ahead, we expect to accelerate revenue by engaging with big brands across all three of our platforms.”
As the demand for data insights increase, SRAX is confident in growth prospects across its verticals. During Q3, the Company raised $5.5 million through a registered direct offering. As of September 30, 2019, SRAX reported being debt free, having cash and cash equivalents on hand of $2.8 million, and having approximately 13.9 million shares outstanding compared to 9.9 million in September 2018.
The best way to understand the BIGtoken platform is to join and discover how surveys are conducted and consumers are given control over personal data.
For more information, visit the company’s website at www.SRAX.com
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced release of the first of its ‘Cannabis 2.0’ products, including Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges. According to the update, shipments of the custom-designed cartridges were sent to Manitoba, Saskatchewan, Ontario, New Brunswick and Nova Scotia, starting December 17, from the Company’s Moncton production campus. “As a company, bringing the next-generation of cannabis products to market without delay was important to us. We are proud to support access to tested, quality derivative-based products that we expect to help strengthen the regulated market and benefit those who prefer those product types over others,” Organigram CEO Greg Engel said in the news release. “Being one of the first licensed producers in the country ready to provide vape products, following the expiration of Health Canada’s 60-day notification period, illustrates that degree of focus and commitment. It speaks to an extraordinary effort by our internal teams who helped bring the Trailblazer Torch to market.”
To view the full press release, visit http://cnw.fm/aC42I
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
December 23, 2019
For the past few years, cannabidiol (CBD) has held the medical, health and wellness and sports communities enthralled. If you’ve been paying any attention to the news, chances are you’ve heard of it too. The compound was barely known three years ago, but now it’s gracing the top of search lists and experts claim the hemp/CBD market will be worth billions by 2026.
Cannabidiol’s main draw lies in its medicinal properties. It is a potent and versatile medicine, with users claiming it gave them relief from a variety of medical conditions including high blood pressure, anxiety, and depression. Last year, the U.S. Food and Drug Administration approved Epidiolex, a CBD-based drug to treat seizures in two rare pediatric disorders Lennox-Gastaut Syndrome and Dravet Syndrome.
However, CBD was an exception from the norm. Usually, it takes the FDA at least two years to draw up a regulatory framework for a new product that’s about to hit the shelves. The CBD industry, on the other hand, ballooned so quickly and at such massive rates that regulatory authorities were left playing catch up.
This left the sector in an awkward position. Although the 2018 Farm Bill had made it legal to grow and sell hemp and products made from hemp extracts, the industry was massively unregulated. In just a year, the market was filled with thousands of untested and unregulated products. On top of that, hemp farmers were denied essential services such as banking and insurance as the providers shied away from the sector.
In a bid to reign in the industry and provide it with a sense of direction, federal lawmakers have granted the FDA and the U.S. Department of Agriculture (USDA) $2 million for research, policy evaluation, market surveillance and issuance of an enforcement discretion policy.
According to the legislation, the FDA has 60 days to report the Agency’s progress towards obtaining and analyzing data that will help determine a policy of enforcement discretion, and how CBD products that fall squarely under the legal definition of hemp will be evaluated for use in products.
It has also been granted 180 days to perform a sampling study of CBD products that are currently in the market to determine the extent to which the products are mislabeled or adulterated.
The Natural Product Association (NPA), based in Washington, D.C, argues that the legislation doesn’t do enough to protect consumers.
“While providing funding for testing is a positive first step, unfortunately, today’s action falls short of what is needed to protect consumers. The future of the U.S. hemp industry and the farmers and producers who provide it are directly tied to smart regulations for CBD, which includes the FDA establishing a safe level of consumption so consumers are protected,” says NPA President and CEO, Daniel Fabricant.
“We are concerned that if Congress fails to act next year then we could see another vaping-like public health crisis.”
Experts think that cannabidiol companies, such as Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) had hoped for more but this FDA funding is a beginning on the long journey towards a regulated and stable CBD market.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently announced further advances in its proprietary, oral, drug-delivery platform: DehydraTECH(TM). An article discussing the company reads, “Lexaria’s early pilot-stage human trials with tetrahydrocannabinol (THC) delivery show its newest formulation of DehydraTECH-enhanced edibles begin providing cannabinoid effectiveness in less than 10 minutes, which is about twice as fast as traditional DehydraTECH and four to six times faster than generic industry formulations, according to a company news release (http://cnw.fm/2owxO). . . . Lexaria has been developing DehydraTECH solutions as alternatives to smoked or vaped drug delivery over the course of the past three years, establishing a means whereby edible consumption of certain substances can provide results at rates comparable to inhaled substances and faster than ingested substances in general.”
To view the full article, visit http://cnw.fm/vOF1Y
About Lexaria Bioscience Corp.
Lexaria Bioscience is a global innovator in drug-delivery platforms. The company’s patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
In the past six months, negative news has become the norm talking about marijuana stocks. While this may be the present state of the industry, it seems as though there are some pot stocks that are definitely worth watching. These few companies are making big moves that should help them move into the future of the industry. With all eyes set on the next few years, innovation is leading the charge right now.
One of the key things to note is that the value in the cannabis industry may not be where most expect to find it. Because the industry covers such a broad scope, the real value is hiding amidst the sub-sectors of the market. These areas include money transport, realty services, extraction businesses and more. With so many to choose from, these two key pot stocks are definitely ones to watch moving forward.
Marijuana Stock To Watch: A Cannabis Cultivator
OrganiGram Holdings (OGI Stock Report) is one of the largest pot stocks in the market. The company was able to push out as much as CA$80 million in revenue for the year ending results. With this, the company also posted around CA$9.5 million in losses for 2019. This number may sound like a lot, but considering the losses of CA$22 million in the previous year, it becomes smaller. The company has been working to up its production of the substance by producing 16 new rooms for the growth of the substance.
This is all being done in its Moncton, New Brunswick facility. With these new growing areas, the company should be able to push out as much as 90,000 kilograms of cannabis when operating at peak capacity. This is quite a lot, and will only payout if the company has a valid source of demand for the product. Only time will tell how well OrganiGram is able to fair with growing concerns of over-production in the Canadian area of the cannabis market.
Marijuana Stocks To Watch: Focusing On A Canadian Cannabis Company
Aleafia Health (ALEAF Stock Report) (ALEF)is another one of the big Canadian pot stocks to watch. The company saw its medicinal cannabis sales rise by as much as 43% from the previous quarter of the same year. With eyes set on being one of the largest sellers of cannabis in Canada, the company still definitely has a long way to go. Many believe that Aleafia Health is positioned to be one of the top players in the Canadian market as its current state of business presents some new and interesting opportunities.
The company has consistently been able to execute its operational practices in the form of new outdoor growing areas. The company states that it expects high levels of cultivation to be one of the leading reasons behind its success in the near future. The hopes are high that Aleafia Health can keep up its momentum as the future continues to weed out the big guys from the smaller pot stocks.
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company, today announced the timing for the payment of its declared regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: YGYIP) for December 2019. According to the update, the dividend will be payable on January 15, 2020 to holders of record as of December 31, 2019. The dividend will be paid in cash.
To view the full press release, visit http://cnw.fm/GqK90
About Youngevity International, Inc.
Youngevity International, Inc. (NASDAQ: YGYI, YGYIP), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit www.YGYI.com.
NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
December 20, 2019
- SRAX offers consumers ability to receive payment for release of their data
- Company’s emphasis is on protection of individuals’ personal information, a critical element in today’s data world
- SRAX’s BIGtoken platform provides advertisers access to verified consumer data
SRAX Inc. (NASDAQ: SRAX) is a digital marketing and data management technology company providing marketers and consumers tools to unlock the value of data. Privacy and data ownership are the Company’s emphasis. Headquartered in Los Angeles, SRAX focuses on offering consumers the ability to own their data and receive payment for the release of it. SRAX is in the process of building the most valuable opted-in consumer data set in the world.
The protection of individuals’ personal information is a major issue today. Recently, the Consumer Online Privacy Rights Act (COPRA) was officially introduced in the U.S. Senate. The strict proposal would give U.S. citizens the same privacy rights that citizens of the European Union have under the General Data Protection Regulation (GDPR) and has serious implications for United States companies.
“With COPRA in place, consumers would have the right to request which data companies are collecting and ask for that data to be deleted or corrected,” noted an article written by the BIGtoken team (http://nnw.fm/EKq2P). “Companies would also need to get explicit consent from anyone before collecting and sharing their data.”
SRAX is at the vanguard of developing a consumer-managed data marketplace and giving consumers control over their information – a power previously unavailable to consumers. The SRAX BIGtoken platform allows consumers to own and monetize their data. This control is significant because today’s consumers expect to receive compensation for releasing their data, while at the same time keeping that data safe, secure and private.
BIGtoken essentially enables consumers to control which pieces of their own data are for sale and which companies can buy them. In addition, BIGtoken provides advertisers access to verified consumer data to better reach and serve audiences. With privacy issues and concerns regarding social media channels such as Facebook, Twitter, Snapchat, LinkedIn and others on everyone’s radar, SRAX offers a premier solution via BIGtoken as the platform creates a secure and transparent environment for consumers. The opportunity to earn money from the release of data has resulted in BIGtoken racking up more than 16 million users around the world thus far, with that number growing every day.
Once consumers grant BIGtoken access to their information, a cooperative relationship is established between SRAX and its customers. Consumers who sell access to their digital data receive compensation with points that they can redeem for cash or gift cards. At the same time, BIGtoken is able to provide verified, high-quality data to advertisers that pay a premium to access consumer-corroborated information for their campaigns. SRAX does not sell BIGtoken data directly to advertisers; it sells access to the data, in the form of anonymized segments.
Along with BIGtoken, SRAX’s product family includes SRAX IR, SRAX Shopper, SRAX Core and SRAX Lux. SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. SRAX Shopper delivers a cross-channel, premium digital experience at scale to high-value shopper audiences. SRAX Core offers one complete dashboard to manage digital media campaigns, inventory and reporting. SRAX Lux targets and reaches luxury consumers at luxury retail stores and high-end art galleries, as well as music, film, fashion and sports events.
SRAX is committed to its mission of delivering tools to unlock the value of data, benefitting consumers and advertisers alike. Significant for investors is that through monetizing its data sets, SRAX is growing numerous, recurring revenue streams by way of its different platforms. SRAX is offering everyone in the internet ecosystem choice, transparency and compensation – coupled with a commitment to privacy and data ownership.
For more information, visit the company’s website at www.SRAX.com
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
GP Solutions (OTC: GWPD), the developer of modular automated micro-farms, on Wednesday announced that GrowPods may help reduce foodborne illnesses. The update highlighted food grown in Controlled Environment Micro-Farms, such as GrowPods, as a way of providing automated cultivation of clean, uncontaminated vegetables, herbs and leafy greens, and included quotations from various publications and others outlining the benefits of farming in controlled environments. “Inside a GrowPod, the air and water are filtered, and since it is a sealed environment, there is little chance for contamination,” according to Business Management News.
To view the full press release, visit http://nnw.fm/f0oLw
About GP Solutions, Inc.
GP Solutions, Inc. is the developer of highly innovative automated micro-farms trade named “GrowPods.” GrowPods are a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. Offering fully insulated, food-grade shipping container that has been specifically modified to provide the optimum controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. With the company’s combination of hydroponic and certified organic soil systems, clients can produce a significantly higher yield that grows faster, healthier and more consistent. For more information, visit the company’s website at www.GrowPodSolutions.com.
NOTE TO INVESTORS: The latest news and updates relating to GWPD are available in the company’s newsroom at http://nnw.fm/GWPD
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
December 19, 2019
Just a year after the 2018 Farm Bill legalized the industrial use of hemp and its extracts, the market for cannabidiol (CBD), one of hemp’s main extracts, had grown so rapidly it had quickly outpaced regulatory authorities. After months of pressure from stakeholders and politicians, the United States Department of Agriculture (USDA) released its interim final rule on hemp.
However, as the sector adjusts to the new regulations, there have been fears that they may be a little too tough, especially on the budding smokable hemp industry. Observers and farmers alike fear that the USDA’s insistence on testing the topmost part of the plant, the flower, for THC concentration will leave a large number of farmers counting huge losses.
Ryan Pettigrew, a hemp consultant based in Fort Collins, Colorado, concurs. “They basically killed the smokable hemp flower market in this country when it was really starting to build steam, and it presented no rational positive concern besides the typical government fear-mongering, ‘Reefer Madness’ nonsense,” he argues.
The new regulations require all hemp plants to be tested by federal, state or otherwise approved agents in U.S. Drug Enforcement Administration (DEA) registered labs 15 days before harvest. The agents will test one plant per acre from the top 8-10 inches of the plant.
The topmost part of the plant, coincidentally, contains the highest concentrations of CBD and THC, and farmers argue this could make most of their crop test above the legal limit.
Casey Flippo, CEO, and co-founder of extraction firm Natvana in Little Rock, Arkansas says that with the new regulations, there will be zero plants grown to maturity. “It’s almost impossible until the genetics catch up to the market. There are some genetics out there that are currently being developed for little to no THC, and those are going to be an absolute necessity moving forward.”
He argues that the sampling protocol laid out by the USDA will “annihilate the market” for smokable hemp.
The USDA granted a comment period for interested parties to offer suggestions before the regulations became permanent. A lot of the commenters have proposed another sampling procedure; test the entire plant to get a more realistic expression of THC across the entire plant.
Scott Propheter, vice president of Agronomy and Outreach at Criticality, a vertically integrated hemp and CBD company in North Carolina, says that there’s a deep lack of understanding about the many variables involved in growing hemp.
“We know that farmers will be negatively impacted if the USDA rules go into place as is because right now, nobody knows enough about the genetics. Then you throw all sorts of other uncertainties into the mix, with weather, soil types, microclimates, and there are a million different variables that we just don’t know enough about.”
Industry watchers are certain that hemp companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) are watching keenly to hear how the USDA responds to these concerns since the future of the industry is at stake.
About HempWireNews
HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.HempWireNews.com
Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer
Do you have a questions or are you interested in working with HWN? Ask our Editor
HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net
HempWireNews is part of the InvestorBrandNetwork.
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) this morning announced that its CAMP Animal Face Solventless Rosin received two awards during the week of December 9, 2019. The product was credited as best Indica vape pen cartridge at the Jack Herer Cup Las Vegas and recognized as best vape pen cartridge at the High Times Nevada Cup. “The recognition of CAMP by both the Jack Herer Cup and High Times is a truly meaningful accomplishment. Our Head Processor, Aaron Nino, and his team, along with our cultivation, merchant, and marketing teams, are doing remarkable work to bring innovative product assortments to the industry,” Green Growth Brands COO Randy Whitaker stated in the news release. “Upon launch, CAMP solventless rosin immediately had commercial success with consumers, and we are really excited that it received the same reception from industry experts. We can’t wait to continue to grow the brand and expand to additional states, starting with Massachusetts this spring.”
To view the full press release, visit http://cnw.fm/udW24
About Green Growth Brands
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida and the largest network of CBD shops in malls across the country and ShopSeventhSense.com. For more information, visit the company’s website at www.GreenGrowthBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, services, and platform solutions to the worldwide life sciences industry, today announced financial results for the third quarter ended September 30, 2019, provided a business update and offered limited guidance for FY2020. “We have consistently highlighted the importance of the “razor/razor blade” business model. In the 3rd quarter, consumable sales for our pressure cycling technology (“PCT”) platform exceeded $100,000/quarter for the first time, increasing by 158% over the same quarter last year,” PBI President and CEO Richard T. Schumacher said in the news release. “A significant portion of this accelerating growth came from scientists working in cancer research centers worldwide. These researchers use PBI’s PCT platform in studies focused on improving cancer diagnostics, prognostics, therapeutics, and prevention. For example, on October 1st we announced that the research group led by nationally acclaimed cancer researcher Dr. Tom Conrads (Sr. Director of Women’s Health Research at the Inova Women’s Hospital, Fairfax, VA) had developed a novel workflow that could enable the identification of biomarkers associated with women’s cancers and possibly result in significant improvements in the clinical management of gynecologic cancer. Dr. Conrads’ comments highlighted that PBI’s PCT platform was an essential part of their workflow.”
To view the full press release, visit http://nnw.fm/Fh9Sd
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
December 19, 2019
Just a year after the 2018 Farm Bill legalized the industrial use of hemp and its extracts, the market for cannabidiol (CBD), one of hemp’s main extracts, had grown so rapidly it had quickly outpaced regulatory authorities. After months of pressure from stakeholders and politicians, the United States Department of Agriculture (USDA) released its interim final rule on hemp.
However, as the sector adjusts to the new regulations, there have been fears that they may be a little too tough, especially on the budding smokable hemp industry. Observers and farmers alike fear that the USDA’s insistence on testing the topmost part of the plant, the flower, for THC concentration will leave a large number of farmers counting huge losses.
Ryan Pettigrew, a hemp consultant based in Fort Collins, Colorado, concurs. “They basically killed the smokable hemp flower market in this country when it was really starting to build steam, and it presented no rational positive concern besides the typical government fear-mongering, ‘Reefer Madness’ nonsense,” he argues.
The new regulations require all hemp plants to be tested by federal, state or otherwise approved agents in U.S. Drug Enforcement Administration (DEA) registered labs 15 days before harvest. The agents will test one plant per acre from the top 8-10 inches of the plant.
The topmost part of the plant, coincidentally, contains the highest concentrations of CBD and THC, and farmers argue this could make most of their crop test above the legal limit.
Casey Flippo, CEO, and co-founder of extraction firm Natvana in Little Rock, Arkansas says that with the new regulations, there will be zero plants grown to maturity. “It’s almost impossible until the genetics catch up to the market. There are some genetics out there that are currently being developed for little to no THC, and those are going to be an absolute necessity moving forward.”
He argues that the sampling protocol laid out by the USDA will “annihilate the market” for smokable hemp.
The USDA granted a comment period for interested parties to offer suggestions before the regulations became permanent. A lot of the commenters have proposed another sampling procedure; test the entire plant to get a more realistic expression of THC across the entire plant.
Scott Propheter, vice president of Agronomy and Outreach at Criticality, a vertically integrated hemp and CBD company in North Carolina, says that there’s a deep lack of understanding about the many variables involved in growing hemp.
“We know that farmers will be negatively impacted if the USDA rules go into place as is because right now, nobody knows enough about the genetics. Then you throw all sorts of other uncertainties into the mix, with weather, soil types, microclimates, and there are a million different variables that we just don’t know enough about.”
Industry watchers are certain that hemp companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) are watching keenly to hear how the USDA responds to these concerns since the future of the industry is at stake.
About HempWireNews
HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.HempWireNews.com
Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer
Do you have a questions or are you interested in working with HWN? Ask our Editor
HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net
HempWireNews is part of the InvestorBrandNetwork.
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) this morning reported the termination of its proposed business combination as the market adapts to the shifting macro environment. Green Growth Brands has agreed to repay the advance of $5 million by January 31, 2020 and to reimburse Moxie $4 million in deal fees on or before July 1, 2020, with both payments to be made in cash. There is no break fee to be paid in connection with the termination. The company plans to continue its aggressive growth strategy in both the MSO and CBD businesses. Green Growth’s MSO business currently includes a 47-dispensary rollout in three key states. The company intends to continue its expansion in this line of business, opening the remaining 45 dispensaries. “We are aggressively growing our businesses across America as we drive to become a leading cannabis retailer in the country,” Green Growth Brands CEO Peter Horvath stated in the news release. “While we continue to be open to collaborating with other industry leaders, we need to ensure we are focused on building our operational strengths, maximize our returns and, most importantly, avoiding excessive dilution to our shareholder base.”
To view the full press release, visit http://cnw.fm/Vv88L
About Green Growth Brands
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida and the largest network of CBD shops in malls across the country and ShopSeventhSense.com. For more information, visit the company’s website at www.GreenGrowthBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
Pressure BioSciences (OTCQB: PBIO) (“PBI”) today announced that it will host a teleconference to discuss its third quarter 2019 financial results and to provide a business update. According to the update, Pressure BioSciences will include in the discussion progress made in its development of instrumentation for the nanoemulsification of oil and water. The call is scheduled to be held at 4:30 PM ET on Thursday, December 19, 2019. Interested parties may join the teleconference by dialing (844) 602-0380 (North America) or (862) 298-0970 (International) and providing passcode: PBI Third Quarter 2019 Financial Call & Business Update. For those unable to attend the live teleconference, a replay will be available beginning Friday, December 20, 2019, accessible on the company’s website and by dialing (877) 481-4010 (North America) or (919) 882-2331 (International) and entering passcode: 57001.
To view the full press release, visit http://nnw.fm/yg8Gv
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
December 18, 2019
Cannabis and its extracts have been seeing a slew of legislative changes, pushing it out of the shadows of illegality. Oklahoma was one of the first states to approve the use of hemp extract cannabidiol (CBD) with a doctor’s recommendation way back in 2016.
However, even with that, the compound was heavily restricted until Governor Ken Stitt approved the passing of Senate Bill 238 that decriminalized the use of CBD oil in Oklahoma.
Before the bill was passed, CBD sellers were subject to heavy restrictions. They weren’t allowed to claim that their products had medical benefits, forcing them to list their businesses as food retailers. On top of that, they had to apply for a yearly license that cost as much as $335 dollars, and they could only sell CBD oil to patients with official doctor recommendation.
According to the newly passed SB 238, sellers can now sell hemp-derived CBD oil and they don’t need to apply for a yearly license. State grown and cultivated hemp is to be used to produce CBD products, although hemp grown in other states can be used under compliance with Federal hemp laws. Additionally, the products should conform to FDA standards regarding hemp processing.
The Bill also states that full-spectrum hemp and hemp isolates are both legal. Unlike CBD isolate that’s pure CBD, full-spectrum CBD contains terpenes, fatty acids, and other cannabinoids. Full-spectrum CBD is said to be a lot more effective than the isolate as all the components combine and act better and more effectively once used. This is called the entourage effect.
However, the bill fails to mention CBD regulation, a big thorn in the industry’s side. After the 2018 Farm Bill legalized industrial hemp and gave farmers the green light to farm the crop, the CBD industry exploded. It grew so fast that it outpaced the regulatory authorities, leaving them scrambling to draw up regulations for an industry some called the ‘wild west’.
The bill sets no regulations for CBD products, leaving the quality of a large percentage of them in question. The U.S. Food and Drug Administration has sent several warning letters to companies warning them from making baseless medical claims about their products. So, at the moment, consumers will have to use their own discretion when they buy CBD products.
The FDA has made it a little easier by distinguishing companies that prioritize quality and safety. Make sure you buy products from companies that have a CGMP (Certified Good Manufacturing Practices). The FDA will also issue a Certified Organic certification for products that are non-toxic and low impact, meaning no harmful herbicides, fertilizers or pesticides were used.
It is believed that while industry actors, such as The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), may not be entirely pleased by the limitations of that law, they nonetheless see Oklahoma as being several steps ahead of other states that are still having prohibitive CBD laws on their books.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
December 18, 2019
- Sigma Labs Inc.’s PrintRite 3D quality-assurance software well-positioned to disrupt evolving 3D printing industry
- Company recently announced appointment of highly respected software veteran, Mark K. Ruport, as executive chairman
- Ruport intends to leverage company’s market momentum, accelerate growth, and increase shareholder value
Software companies can prove to be exceptionally lucrative and rewarding when they provide critical solutions to complex problems. Sigma Labs Inc. (NASDAQ: SGLB) is in just such an enviable position. The company is the recognized pioneer in the development and commercialization of real-time, computer-aided inspection solutions for the 3D metal printing industry. The 3D printing industry is poised for explosive growth but has been hampered by the costly sub-par quality yields and complex processes of post-production inspection of 3D printed parts. These parts must meet stringent specifications for use in demanding environments such as aerospace and currently can only be inspected after production using CT scans and other time consuming, costly techniques. SGLB’s innovative technology has disruptive potential in the evolving 3D printing industry.
Sigma Lab’s patented PrintRite 3D quality-assurance software resolves the problem of costly inspection by enabling nondestructive, in-process quality control elements. Unlike anything else on the market, the company’s latest PrintRite3D software integrates inspection, feedback, data collection, and critical analysis into a unified platform. For the first time in the industry, Sigma Lab’s PrintRite 3D allows errors to be corrected in real time in process, leading to reduced costs and increased manufacturing yields.
Sigma Labs’ PrintRite3D has been third party validated for efficacy, and the company has already engaged 19 beta customers with many of the biggest players in the industry. Two of these programs, after realizing the technology’s benefits during the beta stage, have awarded Sigma Labs Phase 2 contracts for its rapid test and evaluation program, the last step before full commercial orders.
To turbocharge these efforts, Sigma Labs recently announced the appointment of the highly respected software veteran, Mark K. Ruport, to the post of executive chairman. Mr. Ruport brings a stellar resume of building companies through strategic relationships, joint development agreements, innovative sales strategies and a focused management of day-to-day operations. Teaming with CEO and board member John Rice, he intends to leverage the company’s market momentum, accelerate its growth and increase shareholder value.
With over 30 years of public and private company experience in the software sector, Mr. Ruport has a wealth of experience in driving value while guiding software companies to success. He played an instrumental role in multiple transactions that have delivered enormous shareholder value.
Prior to joining Sigma Labs, Mr. Ruport served as Executive Chairman of Content Analyst Company, a leading developer of advanced analytics software until its acquisition by its largest customer in 2017. Previously, he served as president and CEO of Configuresoft, a venture-backed Enterprise Systems Management company where Mr. Ruport orchestrated an OEM contract that later led to the acquisition of the company by EMC. Prior to Configuresoft, Mr. Ruport served as Chairman and CEO of Optika, a venture-backed Enterprise Content Management Company that he led from a start-up of 30 employees through an Initial Public Offering, international growth and a successful transaction to merge with Stellent, Inc., which was subsequently acquired by Oracle. Mr. Ruport was also CEO of Interleaf, a public software company and held senior executive positions at Informix (later acquired by IBM) and Cullinet (later acquired by CA, Inc.).
With so many lucrative, successful transactions under his belt, there should be little doubt about Mr. Ruport’s intentions. An industry heavy weight, his appointment to lead Sigma labs should be indicative of where the company is headed. Sigma Labs’ ability to attract reputable industry talent like Ruport is especially noteworthy to investors.
“The ability to have an immediate, tangible impact on Sigma Labs with the apparent adoption of its incredible technology in the marketplace is a unique and exciting opportunity,” Ruport said in a news release (http://nnw.fm/BY4pN). “My focus will be on accelerating our commercial adoption with strategic partners and amplifying the recent success John and his team have achieved. This blueprint is something I am very familiar with given my experience with disruptive companies in the software sector and I look forward to working with the entire team at Sigma Labs to drive forward its strategic initiatives.”
Ruport’s reputation for value driving and securing lucrative transactions bodes well for SGLB’s increasing presence in the 3D printing industry; the company’s “incredible technology” offers lucrative potential for current shareholders.
For more information, visit the company’s website at www.SigmaLabsInc.com
NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Controlled Environmental Farming such as GP Solutions’ GrowPods may help curb the incidence of food contamination
COLTON, Calif., Dec. 18, 2019 — GP Solutions (OTC:GWPD), the developer of modular automated micro-farms, says that GrowPods may help reduce foodborne illnesses.
The Centers for Disease Control (CDC) estimates that each year roughly 1 in 6 Americans (or 48 million people) gets sick and 3,000 die of foodborne diseases from pathogens including: Norovirus, Salmonella, Staphylococcus, and E. coli. And this problem seems to only be getting worse.
With the holidays and family gatherings upon us, how can consumers help protect themselves from tainted food? One way is to look for food grown in Controlled Environment Micro-Farms, such as GrowPods. These portable indoor growing facilities provide automated cultivation of clean, uncontaminated vegetables, herbs and leafy greens.
“Inside a GrowPod, the air and water are filtered, and since it is a sealed environment, there is little chance for contamination,” according to Business Management News.
Food Technology Magazine states, “The appeal is clear. Growing in a controlled indoor environment is local and sustainable; it requires far less water than outdoor growing, and it doesn’t deplete the soil. Because of their closed systems, many indoor growers use no pesticides. And produce can be bred for garden-fresh taste rather than for the ability to withstand the rigors of a distribution cycle that spans thousands of miles.”
Controlled Environment Farming has also grabbed the attention of celebrity chefs including Carla Hall and Tom Colicchio, and private equity investors because they see the potential for big wins.
“Venture capitalists are really interested in massive market opportunities where you can deploy technology and get a really big outcome,” notes Allison Kopf, founder of Agrilyst. “Agriculture traditionally has been a very massive industry that has been underserved by technology.”
For more information, visit: www.growpodsolutions.com, or call: (855) 247-8054.
Forward-Looking Statements
This release includes predictions or information that might be considered “forward-looking” within securities laws. These statements represent Company’s current judgments, but are subject to uncertainties that could cause results to differ. Readers are cautioned to not place undue reliance on these statements, which reflect management’s opinions only as of the date of this release. The Company is not obligated to revise any statements in light of new information or events.
Connect:
Website: www.growpodsolutions.com
Facebook: facebook.com/GrowPodTechnology
Twitter: @GrowPodSolution
Media:
hello@inov8.us
SRAX (NASDAQ: SRAX), a digital-marketing and consumer data-management technology company, today released results from a survey conducted by the company’s BIGtoken mobile app that shines a light on the multifaceted political issues that impact voting decisions. The survey of 25,469 Americans was conducted in December 2019 and has a less than a +/- 1% margin of error. Per the survey, 29% of all respondents said they’d vote for a Democrat, while 25% are planning to vote for a Republican. Important topics with a “moderate to extreme” effect on women voters included healthcare costs (76%), universal healthcare (70%), student loans (67%), and immigration (63%). “What we’re seeing in the data is a harbinger of the election results but perhaps a bit of a myth-buster also,” SRAX COO and BIGtoken co-founder Kristoffer Nelson stated in the news release. “We see some supposedly ‘hot-button’ issues that don’t matter as much as we might have thought, while other topics are critical to forming voting opinions. In general, women are making their own conclusions about the political climate despite what controversies they may be reading in the popular press. It’s critical to keep an eye on changing attitudes, and platforms like BIGtoken provide an ideal mechanism for brands and businesses to measure the pulse of today’s consumers.”
To download the full ‘Political Perspective Report’, visit http://nnw.fm/U2Gab
To view the full press release, visit http://nnw.fm/gEW2Z
About SRAX Inc.
SRAX is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple, recurring revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor-relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Valuations have been dropping and it could be a good opportunity for cannabis investors to take advantage of some relatively low prices.
Dec 18, 2019 at 7:30AM
Investors have been used to paying big premiums to own marijuana stocks in the past. However, with pot stocks falling sharply over the past several months, valuations have come down sharply. The three stocks listed below have all declined by more than 50% since July 1. However, let’s take a look to see if they’ve become good buys today or if there is still too much risk to invest in them.
1. OrganiGram
OrganiGram Holdings (NASDAQ:OGI) lost nearly 60% of its market cap in the past six months. The cannabis producer released its year-end results in November, which showed OrganiGram’s net revenue was $80.4 million Canadian dollars for the 2019 fiscal year, more than six times the CA$12.4 million it posted in the prior year. Unfortunately, amid all the growth, the company still incurred a loss of CA$9.5 million in fiscal 2019, compared to a profit of CA$22.1 million a year ago.
However, things could improve for the company as OrganiGram expects to be a big player in the cannabis edibles market, especially when it comes to chocolate. On Dec. 13, the company announced Health Canada approved 16 additional rooms for cannabis cultivation. OrganiGram now has a licensed capacity of 89,000/kg per year out of its Moncton, New Brunswick headquarters.
Currently, OrganiGram is trading at around seven times its sales and a price-to-book (P/B) multiple of 1.7. It’s a decent price for a cannabis stock that’s valued at a modest market cap of $400 million, which could have a lot of potential in the edibles market. OrganiGram looks like one of the better buys in the industry today.
2. Aurora Cannabis
Aurora Cannabis (NYSE:ACB) is not an under-the-radar stock like OrganiGram, as its market cap of $2.8 billion makes it one of the top pot stocks in the world. Like Organigram, Aurora has seen its share price crater over the past six months, falling by 65%.
The company has struggled with profitability and meeting analyst forecasts, as it has recorded a loss in three of the past four quarters. Its net loss over the trailing twelve months totaled CA$383.5 million on sales of CA$293.5 million. Meeting expectations won’t get any easier now that the company’s sales in Germany have been halted after it failed to get a permit for what Chief Operating Officer Cam Battley said is “treatment that we use to maintain the product without microbial contamination.” Investors learned of the temporary hold on sales in November, and the company expects that operations will go back to normal “very early in the new year.”
It’s a setback that is only going to make things more challenging for Aurora for its current quarter. Currently, Aurora is trading at more than 12 times its sales and its P/B is at 0.80. Given that investors could be disappointed again when the company reports its Q2 results in February, even these relatively low multiples may make Aurora too expensive to buy today, as there could be further losses for the stock in the months to come.
3. Tilray
Tilray (NASDAQ:TLRY) has suffered the largest losses out of the stocks listed here, dropping more than 70% since the beginning of the year. Tilray has lost half of its value in just six months. The peak price of $300 that it reached last year is just a distant memory, as even trading above $20 is a challenge for the stock today.
The company has incurred a net loss in each of the past four quarters, and while the losses have been stable, there hasn’t been a progression toward breakeven. Over the trailing twelve months, Tilray’s net losses of $132 million have nearly been as large as its sales of $135.6 million.
What’s been disappointing about Tilray’s recent results is just how little sales it generated from the adult-use market — $15.8 million. Although its revenue is diverse, Tilray has generated more in hemp product sales over the past nine months than it has in revenue from the adult-use market. This may change in future quarters as the cannabis market in Canada continues to evolve and as more pot shops come online, but it’s something that investors should keep a close eye on going forward.
The stock is currently trading at around 15 times its sales and 4.5 times book value, making it the most expensive stock to own among the three listed here. Like Aurora, it’s still a bit of an expensive buy given the question marks surrounding the company’s financials.
Valuations in the industry remain high
As noted above, pot stocks suffered significant losses in 2019, but that doesn’t mean that they’ve become cheap buys. OrganiGram is the only stock of these three that may offer investors good value, and that still depends on its ability to do well in the edibles segment.
When investing in pot stocks, investors shouldn’t neglect to look at how close a company is to breaking even and how much of a premium they’re paying to own a piece of the company. Now that the hype surrounding the industry has worn off, valuation principles will play much more of a role in the industry’s future, and that’s why it’s more important than ever to pay attention to sales and earnings multiples.